Rational design and characterisation of a linear cell penetrating peptide for non-viral gene delivery

The design of a non-viral gene delivery system that can release a functional nucleic acid at the intracellular destination site is an exciting but also challenging proposition. The ideal gene delivery vector must be non-toxic, non-immunogenic, overcome extra- and intra-cellular barriers, protect the...

Full description

Saved in:
Bibliographic Details
Published in:Journal of controlled release 2021-02, Vol.330, p.1288-1299
Main Authors: McErlean, Emma M., Ziminska, Monika, McCrudden, Cian M., McBride, John W., Loughran, Stephen P., Cole, Grace, Mulholland, Eoghan J., Kett, Vicky, Buckley, Niamh E., Robson, Tracy, Dunne, Nicholas J., McCarthy, Helen O.
Format: Article
Language:English
Subjects:
Cell penetrating
Gene delivery
Linear peptides
Non-viral
Nucleic acids
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The design of a non-viral gene delivery system that can release a functional nucleic acid at the intracellular destination site is an exciting but also challenging proposition. The ideal gene delivery vector must be non-toxic, non-immunogenic, overcome extra- and intra-cellular barriers, protect the nucleic acid cargo from degradation with stability over a range of temperatures. A new 15 amino acid linear peptide termed CHAT was designed in this study with the goal of delivering DNA with high efficiency into cells in vitro and tissues in vivo. Rational design involved incorporation of key amino acids including arginine for nucleic acid complexation and cellular uptake, tryptophan to enhance hydrophobic interaction with cell membranes, histidine to facilitate endosomal escape and cysteine for stability and controlled cargo release. Six linear peptides were synthesised with strategic sequences and amino acid substitutions. Data demonstrated that all six peptides complexed pDNA to produce cationic nanoparticles less than 200 nm in diameter, but not all peptides resulted in successful transfection; indicating the influence of peptide design for endosomal escape. Peptide 4, now termed CHAT, was non-cytotoxic, traversed the plasma membrane of breast and prostate cancer cell lines, and elicited reporter-gene expression following intra-tumoural and intravenous delivery in vivo. CHAT presents an exciting new peptide for the delivery of nucleic acid therapeutics. [Display omitted]
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2020.11.037